Biocompatible Nanoparticles as a Platform for Enhancing Antitumor Efficacy of Cisplatin–Tetradrine Combination

Biocompatible Nanoparticles as a Platform for Enhancing Antitumor Efficacy of Cisplatin–Tetradrine Combination

Abstract Combination therapy has been a standard strategy in the clinical tumor treatment. We have demonstrated that combination of Tetradrine (Tet) and Cisplatin (CDDP) presented a marked synergistic anticancer activity, but inevitable side effects limit their therapeutic concentration. Considering...

Full description

Bibliographic Details
Main Authors: Fangcen Liu, Xinyue Wang, Qin Liu, Huan Zhang, Li Xie, Qin Wang, Lin Li, Rutian Li
Format: Article
Language:English
Published: SpringerOpen 2021-04-01
Series:Nanoscale Research Letters
Subjects:
Copolymer
Nanoparticles
Combination therapy
Cisplatin
Tetradrine
Online Access:https://doi.org/10.1186/s11671-021-03511-4

Internet

https://doi.org/10.1186/s11671-021-03511-4

Similar Items